Tag Archives: ILMN

Illumina (ILMN) Receives a Buy from Credit Suisse

In a report released yesterday, Lorenzo Biasio from Credit Suisse maintained a Buy rating on Illumina (ILMN – Research Report), with a price target of $340. The company’s shares closed yesterday at $299.38. According to TipRanks.com, Biasio is a 3-star

Analyst Explains Why They Downgraded Their Rating on Illumina (ILMN)

Canaccord Genuity analyst Mark Massaro downgraded Illumina (ILMN – Research Report) to Hold today and set a price target of $300. The company’s shares closed yesterday at $304.41. Massaro said: “We don’t believe an ultra-premium multiple is now justified for

Illumina (ILMN) Gets a Buy Rating from Canaccord Genuity

In a report released today, Mark Massaro from Canaccord Genuity maintained a Buy rating on Illumina (ILMN – Research Report), with a price target of $360. The company’s shares closed on Friday at $335.49. Massaro said: “We recently had the

New Buy Rating for Illumina (ILMN), the Healthcare Giant

Canaccord Genuity analyst Mark Massaro maintained a Buy rating on Illumina (ILMN – Research Report) today and set a price target of $350. The company’s shares closed yesterday at $319.20. Massaro observed: “We view Q1 as mixed, but we reiterate

Merrill Lynch Keeps a Buy Rating on Illumina (ILMN)

In a report released today, Derik De Bruin from Merrill Lynch reiterated a Buy rating on Illumina (ILMN – Research Report), with a price target of $355. The company’s shares closed yesterday at $285.26. According to TipRanks.com, Bruin is a

Morgan Stanley Keeps a Hold Rating on Illumina (ILMN)

In a report released today, Steve Beuchaw from Morgan Stanley maintained a Hold rating on Illumina (ILMN – Research Report), with a price target of $288. The company’s shares closed on Friday at $302.69. According to TipRanks.com, Beuchaw is a